Download a PDF of the programme.
9th Nordic EMBL Partnership Meeting 2018: Main scientific meeting programme
Day One: Thursday 13 September
8:30-9:00 Poster set up, coffee and tea (Lillesal/coffee point)
Opening session (Storesal)
9:00 Welcome: Hartmut Luecke, Acting Director, NCMM
9:05 – 10:30 Institute Updates
- Poul Nissen, DANDRITE
- Bernt Eric Uhlin, MIMS
- Mark Daly, FIMM
- Hartmut Luecke, NCMM
- Iain Mattaj, EMBL
10:30 – 11:00 Morning coffee break
11:00 – 11:45 Keynote talk: Mark Daly, FIMM, “Finnish opportunities in research and clinical genetics –a global perspective” Chair: Janna Saarela, Assistant Director, FIMM
11:50 – 12:50 Lunch
13.00 Group Photo
13:15 – 14:15 Introducing the Nordic EMBL Partnership’s newly appointed Group Leaders (Storesal) Chair: Judith Staerk, Group Leader, NCMM
- Ellen Bushell, MIMS: “A systematic in vivo genetic analysis of parasite genes modulating pathogen-host interactions and pathology in malaria”
- Emma Haapaniemi, NCMM: “CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response”
- Antti Latvala, FIMM: “Genetic Epidemiology of Substance Use and Mental Disorders”
- Barbara Sixt, MIMS: “Illuminating the Hidden Power of Cell-Autonomous Immunity”
- Jing Tang, FIMM:“Network pharmacology for precision medicine”
- Eero Vuoksimaa, FIMM: “Future challenges in cognitive aging.”
14:15 – 14:30 Short break
14:30 – 16:00 Research from across the EMBL and Nordic EMBL Partnership (Storesal) Chair: Duda Kvitsiani, Group Leader, DANDRITE
- Justin Crocker, Group Leader, EMBL, “Nuclear microenvironments modulate transcription from low-affinity enhancers”
- Taru Tukiainen, Group Leader, FIMM, “Genomic approaches to decipher the extent and impacts of incomplete X chromosome inactivation”
- Kyung-Min Noh, Group Leader, EMBL, “Dynamics and function of histone variant H3.3 in embryonic stem cells and neurons”
- Poul Henning Jensen, Group Leader, DANDRITE “Calcium dysregulations in Parkinson’s disease.”
16:00 – 16:30 Afternoon coffee break
16:30 – 18:00 Research from across the EMBL and Nordic EMBL Partnership (Storesal) Chair:Felipe Cava, Group Leader, MIMS
- Hartmut Luecke, Group Leader and Acting Director, NCMM, “Helicobacter pylori Acid Acclimation: The Evil Duo of a pH-Gated Urea Channel and a Cytoplasmic Urease”
- Stephen Cusack, Group Leader EMBL, “Structure, mechanism and drug targeting of the influenza virus transcription/replication machine”
- William Hennah, Group Leader, FIMM, “Alternative Variables in the Study of Neuropsychiatric Disorders in Finland”
- Cornelius Gross, Group Leader, EMBL, “Learning to hunt: the dynamic neural circuitry of predation.”
18:00 – 18:30: E-poster session (Møterom 1 & 2)**
18:30 – 19:45: Pre-dinner drinks at posters (Lillesal)
20:00 Dinner
Day Two: Friday 14 September
9:00 – 10:30 Research from across the EMBL and Nordic EMBL Partnership (Storesal) Chair: Nikolina Sekulic, Group Leader, NCMM
- Joseph Lyons, Postdoc, DANDRITE, “Structure of a yeast lipid flippases”
- Jonas Ries, Group Leader, EMBL, “High-throughput superresolution microscopy of endocytosis – linking molecular architecture and mechanics of a protein machinery”
- Hiraku Takada, Postdoc, MIMS, “Bacillus subtilis ABCF resistance factor VmlR directly protects the ribosome from antibiotics tiamulin, streptogramin A and virginiamycin M”
- Eva Kowalinski, Group Leader, EMBL, “Structural and functional studies of the cytoplasmic RNA degrading exosome.”
10:30 – 11:00 Coffee break
11:00 – 11:45 Keynote talk: Oliver Billker,MIMS, “Unlocking the unknown biology of malaria parasites” (Storesal) Chair: Sun Nyunt Wai, Group Leader, MIMS
11:45 – 13:00 Research from across the EMBL and Nordic EMBL Partnership (Storesal) Chair: Jing Tang, Group Leader, FIMM
- Emilio Bueno, Postdoc MIMS, “Anaerobic nitrate reduction divergently governs population expansion of the enteropathogen Vibrio cholerae”
- Orsolya Barabas, Group Leader EMBL, “Structural insights into jumping DNA: from antibiotic resistance spreading to genetic tools”
- Judith Staerk, Group Leader NCMM, “Mitochondrial dynamics control human neuronal development by preventing aberrant DNA methylation.”
13:00 Closing remarksfrom Hartmut Luecke, NCMM
13:05 Lunch and departure